Analystreport

Second Sight Medical Products, Inc. (NASDAQ: EYES) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.

Second Sight Medical Products, Inc.  (EYES) 
Last second sight medical products, inc. earnings: 3/19 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.secondsight.com/investor-relations